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Abstract
Background and Aims—Epidemiologic studies have suggested beneficial effects of flavonoids
on cardiovascular disease. Cocoa and particularly dark chocolate are rich in flavonoids and recent
studies have demonstrated blood pressure lowering effects of dark chocolate. However, limited
data are available on the association of chocolate consumption and the risk of coronary heart
disease (CHD). We sought to examine the association between chocolate consumption and
prevalent CHD.
Methods—We studied in a cross-sectional design 4,970 participants aged 25 to 93 years who
participated in the National Heart, Lung, and Blood Institute (NHLBI) Family Heart Study.
Chocolate intake was assessed through a semi-quantitative food frequency questionnaire. We used
generalized estimating equations to estimate adjusted odds ratios.
Results—Compared to subjects who did not report any chocolate intake, odds ratios (95% CI)
for CHD were 1.01 (0.76-1.37), 0.74 (0.56-0.98), and 0.43 (0.28-0.67) for subjects consuming 1-3
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times/month, 1-4 times/week, and 5+ times/week, respectively (p for trend <0.0001) adjusting for
age, sex, family CHD risk group, energy intake, education, non-chocolate candy intake, linolenic
acid intake, smoking, alcohol intake, exercise, and fruit and vegetables. Consumption of non-
chocolate candy was associated with a 49% higher prevalence of CHD comparing 5+/week vs. 0/
week [OR=1.49 (0.96-2.32)].
Conclusions—These data suggest that consumption of chocolate is inversely related with
prevalent CHD in a general population.
Keywords
epidemiology; carbohydrate; nutrition; cardiovascular disease
Introduction
Epidemiologic data have shown that regular consumption of whole grains, fruit, vegetables,
nuts, and perhaps tea is associated with lower incidences of coronary heart disease (CHD)
and stroke1,2. It has been postulated that a higher content of polyphenols in these foods is
partially responsible for the beneficial effects on CHD. Flavonoids are among the most well
studied polyphenols. In the Iowa Women's Health Study, there was an inverse association
between dietary catechins (one of the 6 major subclasses of flavonoids3) and CHD mortality
among postmenopausal women after 13 years of follow up4. The French paradox has been
partially attributed to a higher consumption of wine in France. Wine, especially red wine,
contains polyphenolic compounds with possible health benefits. In a meta-analysis, Di
Castelnuovo et al.5 reported that consumption of 150 ml/d of wine was associated with 32%
reduction of CVD risk. Dark chocolate is another flanonoid-rich food that may have health
benefits. Besides nutrients such as saturated fat (60%), monounsaturated fat (35%), and
linoleic acid (3%), chocolate contains important minerals such as potassium and magnesium
and flavonoids (particularly epicatechin) that might lower the risk of CHD6,7. In a
randomized crossover trial of 13 healthy subjects, daily consumption of 100 g of dark
chocolate for 14 days was associated with 5.1 mm Hg decline in systolic blood pressure (p
<0.001) and 1.8 mm Hg decline in diastolic blood pressure compared with baseline8. These
findings on blood pressure have been reproduced by others9. Other studies have shown that
cocoa consumption improved flow-mediated dilation of the brachial artery10-11,12, inhibited
platelet activation and function13, regulated nitric oxide production9, and may exert
favorable effects on cardiovascular mortality14. We have recently reported an inverse
relation between chocolate consumption and subclinical atherosclerosis in the coronary
arteries15.
While the above data support beneficial effects of chocolate on CVD risk factors, limited
data are available on the association between chocolate intake and CHD. In particular, little
is known about the effects of smaller amounts of chocolate consumed by the general
population on CHD. Thus, in the present paper, we sought to examine the association




A detailed description of the NHLBI Family Heart Study has been previously published16.
Briefly, between 1993 and 1995, groups of individuals participating in each of the parent
studies were selected at random and invited to furnish an updated family health history that
contained information on their parents, children, and siblings. Of 4,679 individuals
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contacted, responses were obtained from 3,150 (67%); their family members were then
contacted, and self-reported health data obtained from a total of 22,908 individuals (86% of
those contacted). From the families responding to the health questionnaire, 588 families
were chosen at random and 566 families were selected based on higher than expected risk of
CHD. Families chosen at random are subsequently referred to as random group and those
selected based on a higher than expected risk of CHD are referred to as high-risk group. The
high-risk group was defined based on a family risk score, which compares the family's age
and sex-specific incidence of CHD to that expected in the general population17. All
members of these families were invited to come to one of the four study clinics for an
approximate 4-hour clinical evaluation. Of the total 5,710 Caucasians and 265 African-
Americans, 101 white subjects were excluded because of missing data on CHD and
additional 904 subjects (874 whites and 30 blacks) were excluded because of missing data
on chocolate consumption. Subjects with missing data on chocolate were slightly older than
those with complete data on chocolate; however, other characteristics including body mass
index, glucose, blood cholesterol, race, risk group, or prevalent diabetes were comparable.
Thus, 4,970 participants were used for present analyses. We obtained informed consent from
each participant and the study protocol was reviewed and approved by each of the
participating institutions.
Assessment of chocolate consumption
Dietary information was collected through a staff-administered semi-quantitative food
frequency questionnaire developed by W.C. Willett18. The reproducibility and validity of
the food frequency questionnaire has been documented elsewhere19,20. Each subject was
asked the following question: “In the past year, how often on average did you consume
chocolate bars or pieces, such as Hershey's Plain, M & M, Snickers, Reeses; 1 ounce?” (Item
# 39 in the questionnaire). Possible answers were: “> 6 per day, 4-6 per day, 2-3 per day, 1
per day, 5-6 per week, 2-4 per week, 1 per week, 1-3 per month, and almost never”.
Ascertainment of coronary heart disease
Prevalent CHD was assessed from the medical history and a 12-lead electrocardiogram.
Individuals were defined as a case of CHD if there was a self-reported history of myocardial
infarction, percutaneous transluminal coronary angioplasty, or coronary artery bypass graft
that could be validated by review of medical records, or if abnormal Q waves (Minnesota
codes 1.1-1.2) were detected on a resting 12-lead electrocardiogram21.
Other variables
Resting blood pressure was measured three times on seated participants after a 5-minute rest
using a random zero sphygmomanometer by trained and certified technicians. The
appropriate cuff size was determined by the arm circumference. For analyses, the average
systolic and diastolic blood pressures from the second and third measurements were used.
We used the JNC VII classification to define hypertension (stages 1 or 2 – systolic blood
pressure of at least 140 mm Hg or diastolic blood pressure of at least 90 mm Hg) or if the
subject reported that, he/she was currently taking medications for hypertension.
Information on other dietary factors was obtained through the food frequency questionnaire.
Intake of specific nutrients was computed by multiplying the frequency of consumption of
an item by the nutrient content of specified portions. Composition values for nutrients were
obtained from the Harvard University Food Composition Database derived from the U.S.
Department of Agriculture sources22 and manufacturer information. For non-chocolate
candy assessment, each subject was asked “in the past year, how often on average did you
consume candy without chocolate; 1oz? (Item # 40 of the questionnaire, subsequently
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referred to as non-chocolate candy). Possible responses were similar to those of chocolate
described above.
Information on cigarette smoking, alcohol intake, and education was obtained by interview
during the clinic visit. Use of multivitamins, vitamin E or C, or hormone replacement
therapy was assessed using a questionnaire and medication inventory. Frequency of
vegetable consumption was obtained by a food frequency questionnaire. Physical activity
during the previous year was self-reported. Anthropometric data were collected with
participants wearing scrub suits. A balance scale was used to measure body weight, and
height was measured using a wall-mounted vertical ruler. Diabetes mellitus was defined as
any of the following: (a) a self-reported history of diabetes, (b) fasting glucose of at least 7.8
mmol/L, or (c) current usage of a hypoglycemic agent. Low-density lipoprotein cholesterol
(LDL) was measured using the method of Friedewald23 except for participants with
triglycerides above 4.5 mmol/L, whose LDL was measured by ultracentrifugation.
Triglycerides were measured using triglycerides GB reagent on the Roche COBAS FARA
centrifugal analyzer (Boehringer Mannheim Diagnostics, Indianapolis). Total cholesterol
was performed using a commercial cholesterol oxidase method on a Roche COBAS FARA
centrifugal analyzer (Boehringer Mannheim Diagnostics, Indianapolis). HDL cholesterol
was measured after precipitation of the other lipoprotein fractions by dextran sulfate.
Statistical analyses
We initially examined the distribution of CHD cases according to all possible responses for
chocolate consumption (Never, 1-3/month, 1/week, 2-4/week, 5-6/week, 1/d, 2-3/d, 4-6/d,
and >6/d). However, because there were only 18 and 25 cases for chocolate consumption of
5-6 per week and 1/d or greater, respectively, we combined these groups to have sufficient
number of cases for multivariable analyses. From the lowest to the highest frequency of
chocolate intake, we observed similar inverse relations with CHD in men [1.0 (reference),
0.67 (0.50-0.90), 0.48 (0.37-0.63), and 0.24 (0.16-0.38), p for trend <0.0001] and women
[1.0, 1.10 (0.72-1.68), 0.67 (0.43-1.05), and 0.54 (0.29-0.97), respectively, (p for trend
0.006)] in the crude analyses; in addition, there was no evidence for interaction between sex
and chocolate consumption on CHD (p for interaction 0.28); thus, we analyzed the data with
men and women combined. We used univariate analyses to evaluate potential confounders
and used partial likelihood ratio tests to compare nested models. We built sequential models
as follows: after a crude model, we adjusted for age, sex, and risk group in a simplest model
and also controlled for education, smoking, alcohol intake, energy intake, fruit and
vegetables, exercise, dietary linolenic acid, and non-chocolate candy consumption (4 groups
using frequencies used for chocolate consumption) in a parsimonious model. Then, we
examined potential mediating factors through additional adjustment for body mass index,
diabetes, weight loss diet, lipids, and hypertension. Additional adjustment for field center,
myristic acid or palmitic acid, saturated fat, a composite variable representing foods
frequently avoided in cholesterol-lowering diets (butter, eggs, hot dogs, and hamburgers),
and antioxidant vitamins (E, C, multivitamins) did not alter the results (data not shown).
Because subjects were not independent, we used generalized estimating equations to control
for familial clustering (exploring different correlation matrix structures). P values for linear
trend were obtained by assigning ordinal numbers to chocolate frequency and using the new
variable in the regression model. We conducted sensitivity analyses by a) restricting
analyses to Caucasians, b) excluding subjects with diabetes mellitus or those on weight loss
diet, c) using 5-year age categories, and d) stratified analyses by age (≤ 60 y and >60 y) and
smoking status. We also examined whether chocolate consumption was related to prevalent
hypertension. Alpha level was set at 0.05 for statistical significance. All analyses were
performed using windows SAS version 9.1 (SAS Institute Inc, Cary, NC).
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Of the 4,970 participants used for analysis, 2,258 were men and 2,712 were women. The
mean age (SD) was 52.0 (13.7) years and CHD prevalence was 10.9%. Table 1 presents
baseline characteristics according to chocolate intake. Frequent chocolate consumption was
associated with younger age, higher body mass and energy intake and lower HDL; lower
frequency of fruit and vegetable consumption, wine consumption, multivitamin use; higher
consumption of non-chocolate candy, saturated fat, and dietary cholesterol. Age-, sex-, and
energy-adjusted means of dietary cholesterol, saturated fat, and polyunsaturated fat were
0.21 vs. 0.23 g/d, 0.24 vs. 0.25 g/d, and 9.2 vs. 9.0 g/d when comparing subjects with
prevalent CHD vs. those without CHD, respectively.
There was evidence for an inverse association between frequency of chocolate consumption
and prevalent CHD in crude and adjusted models (Table 2). In the fully adjusted model,
consumption of 5+/week was associated with 57% lower prevalent CHD compared with
subjects who did not consume chocolate (Table 2). Exclusion of subjects with prevalent
diabetes and those who were on weight loss diet made the association stronger: from the
lowest to the highest category of chocolate, ORs were 1.0, 0.98, 0.68, and 0.38 (p for trend
0.0002, Table 3, Model 2). Similar association was observed in subjects who were 60 years
of age or younger and those above the age of 60 (Table 4). Furthermore, similar associations
were seen among smokers and non-smokers (e.g., for the highest category of chocolate
intake, the ORs were 0.44 for smokers and 0.43 for non-smokers). Including a composite
variable for consumption of butter, eggs, hot dogs, and hamburgers resulted in a slight
attenuation of the findings (data not shown). Similar results were seen after additional
adjustment for myristic acid (C14.0) – a saturated fatty acid found in low concentration in
chocolate. In addition, 5-year age categories to control residual confounding by age did not
alter the results (p for trend 0.0002). Finally, restriction to Caucasians did not alter the
findings: from the lowest to the highest category of chocolate consumption, multivariable
adjusted odds ratios (95% CI) were 1.0 (reference), 1.03 (0.76-1.40), 0.75 (0.56-1.01), and
0.44 (0.28-0.70), respectively (p for trend 0.0002). Adjustment for potential intermediate
factors such as lipids, blood pressure, diabetes, measures of adiposity led to a minimal
attenuation [OR: 1.0 (ref), 1.05 (0.77-1.43), 0.75 (0.56-1.01), and 0.43 (0.27-0.68) from the
lowest to the highest category of chocolate, p for trend 0.0002]. There was no association
between chocolate consumption and blood pressure: from the lowest to the highest category
of chocolate consumption, adjusted odds ratios for hypertension were 1.0 (reference), 0.99
(0.77-1.26), 0.96 (0.75-1.23), and 1.11 (0.81-1.53), respectively (p for trend 0.72).
In contrast, non-chocolate candy consumption was suggestive of an increased prevalence of
CHD. Multivariable adjusted odds ratios (95% CI) were 1.0 (ref), 0.96 (0.72-1.27), 1.05
(0.79-1.39), and 1.49 (0.96-2.32) for non-chocolate candy consumption of 0, 1-3/month, 1-4/
week, and 5+/week, respectively, adjusting for age, sex, exercise, energy, linolenic acid,
education, risk group, chocolate consumption, alcohol, smoking, and fruit and vegetables.
Discussion
Chocolate consumption and CHD
In this cross-sectional study, we have demonstrated that frequent chocolate consumption
was associated with a lower prevalence of CHD in men and women independent of
traditional risk factors. Our findings were robust in that exclusion of subjects with prevalent
diabetes and those on weight loss diet did not alter the conclusions. In addition, an inverse
association was seen in subjects under and above 60 years of age as well as in smokers and
non-smokers. In contrast, consumption of non-chocolate candies 5 times or more per week
was suggestive for an 49% increased prevalent CHD compared with no consumption. One
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possible explanation for the observed inverse association between chocolate consumption
and CHD prevalence is confounding by indication. In such a scenario, subjects with
prevalent CHD might have avoided chocolate and other foods rich in saturated fats (per
friends' or clinicians' advice). However, this is unlikely as higher frequency of chocolate
intake was associated with increased consumption of dietary cholesterol and saturated fat in
this study. In addition, there was no clinically meaningful difference in mean dietary
cholesterol, saturated fat, or polyunsaturated fat between subjects with prevalent CHD and
those without CHD. While inclusion of a composite variable for foods frequently avoided in
cholesterol-lowering diets or estimated intake of myristate did attenuate the inverse
association between chocolate and CHD, the association remained statistically significant
and of similar magnitude.
Dark chocolate belongs to the flavonoid-rich foods such as fruit and vegetables, tea, and red
wine. Epidemiologic evidence indicates that beneficial effects of whole grains, fruit,
vegetables, tea, and red wine on CHD are partly mediated through the effects of their
polyphenolic compounds7,24,25. Although, interventional studies have demonstrated
beneficial effects of dark chocolate on blood pressure8,9,26,27 and endothelial function10
11,12, limited data are available on the effects of total chocolate intake on CHD. In the Iowa
Women's Health Study, dietary catechins were inversely associated with coronary heart
disease death4. In that study4, chocolate contributed 6% of total catechins and when
analyzed by catechin source, there was suggestive evidence for an inverse association
between chocolate derived-catechin and CHD death [RR (95% CI): 0.88 (0.71-1.08)] in a
multivariable adjusted model comparing the 3rd with the 1st tertile of catechin. Our data are
also consistent with findings among 19,357 subjects in whom dark chocolate intake was
associated with a 39% lower risk of myocardial infarction and stroke combined [RR: 0.61
(95% CI 0.44-0.87)]28.
Is CHD effect mediated through the effects of chocolate intake on blood pressure?
In the crude data, we observed an inverse association between frequency of chocolate intake
and prevalent hypertension. From the lowest to the highest category of chocolate
consumption, prevalence of hypertension was 18.5%, 14.9%, 13.5%, and 14.0%,
respectively (p for trend 0.001). However, this association did not persist after adjustment
for age, sex, risk group, exercise, fruit and vegetables, non-chocolate candy, energy, alcohol
intake, smoking, education, and linolenic acid (p for trend 0.72). Contrary to our findings, a
meta-analysis of randomized trials reported a mean systolic blood pressure change of -4.5
mm Hg (95% CI: -5.9 to -3.2) in the active treatment arms across all trials; corresponding
change for diastolic blood pressure was -2.5 mm Hg (95% CI: -3.9 to -1.2)29. The
inconsistency between these studies and our findings merits comments. While subjects in the
ten trials meta-analyzed29 were either normotensive healthy subjects, prehypertensive, or
stage 1 hypertensive subjects, our study included subjects with prevalent clinical disease
with a wider range for age. Chocolate consumption in our study was self reported – a
possible source of misclassification, whereas the trials used specific amounts of dark
chocolate per day. Another shortcoming of our study is that we were not able to differentiate
between dark and lighter or milk chocolate. However, since milk chocolate has much lower
content of polyphenols (and is substantially more frequently consumed in the US), inclusion
of subjects consuming exclusively milk or lighter chocolate would have biased our results
towards the null in the absence of an effect of milk of lighter chocolate. Another possible
explanation for the lack of association with hypertension could be the relatively lower
amount of chocolate consumed in our study (only few times per week) compared with 10 to
100 g of chocolate used in intervention studies.
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Possible mediation by lipids, diabetes, and adiposity
Inclusion of potential mediating factors such as adiposity, diabetes, hypertension,
triglycerides, LDL-, and HDL- cholesterol led to a minimal attenuation of the relation
between chocolate consumption and CHD. This suggests that these factors only explain part
of the observed relation. Grassi et al.9 did not find any change in HDL, LDL, or triglycerides
after 15 days of ingesting 100 g of dark chocolate daily. While cocoa butter contains
relatively higher amounts of saturated fat [stearic acid (35%) and palmitic acid (25%)], it has
been suggested that stearic acid does not elevate blood cholesterol concentration like other
saturated fats30,31. A possible explanation for the disparity is hepatic desaturation of stearic
acid into oleic acid, inefficient absorption, or chain length32. Other researchers have
presented evidence supporting neutral effects of cocoa butter on cholesterol33,34. Lastly,
there is evidence from randomized trials suggesting favorable effects of dark chocolate on
total and LDL-cholesterol35. It is important to mention that our findings could be partly
attributable to the lack of adequate intake of dark chocolate in our population to observe a
large effect. We were unable to quantify the proportion of total chocolate contributed by
milk vs. dark chocolate in our sample, as we did not query about such details in the food
questionnaire. Furthermore, our food questionnaire did not query about cocoa or flavonoid
contents, source of chocolate, or chocolate preparation.
Study limitations
The cross-sectional design limits our ability to draw casual inference. In addition,
misclassification and reporting bias are inherent to self-reported data on chocolate
consumption and we were not able to differentiate dark from milk or lighter chocolate.
However, such inability to distinguish the different types of chocolate might have led to an
underestimation of the true association between cocoa/chocolate polyphenol consumption
and CHD in this study. We were unable to determine the polyphenol content of reported
chocolate to contrast our findings with large doses administered in randomized trials where
nutrient content is well documented. In particular, beneficial effects of dark chocolate on
coronary vasodilation and platelet activity have been previously documented36. Of note is
that subjects in our study consumed chocolate only few times per week, indicating that even
smaller amounts of chocolate (with few extra calories) may have beneficial effects on
cardiovascular health. At this point, we are unable to determine the minimum amount of
dark chocolate required for cardiac benefits (although we found beneficial effects only
among subjects reporting intake at least once a week). In addition, we cannot completely
exclude residual confounding or confounding by indication as alternative explanation for
observed findings. Nevertheless, the large sample size (most of whom were from
population-based studies), the availability on multiple CHD risk factors, and the multi-center
nature of the study are strengths of our report.
In conclusion, our findings suggest that chocolate consumption is inversely associated with a
lower prevalence of CHD. Our findings are supported by clinical trials assessing the effects
dark chocolate on blood pressure, platelet function, and endothelial function and suggest that
consumption of small amounts of chocolate might provide additional benefits in reducing
CHD risk.
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Table 2
Prevalence odds ratios (95% confidence intervals) of coronary heart disease according to chocolate
consumption in 4,970 participants in the NHLBI Family Heart Study*
Frequency of chocolate intake Cases/N Crude Model 1† Model 2‡
0 168/1093 1.0 1.0 1.0
1-3 per month 147/1167 0.79 (0.62-1.01) 1.01 (0.76-1.37) 1.05 (0.77-1.43)
1-4 per week 182/1931 0.57 (0.46-0.72) 0.74 (0.56-0.98) 0.75 (0.56-1.01)
5+ per week 43/779 0.32 (0.23-0.45) 0.43 (0.28-0.67) 0.43 (0.27-0.68)
P for linear trend <0.0001 <0.0001 0.0002
*
Coronary heart disease was defined as history of myocardial infarction, PTCA, or CABG.
†
Adjusted for age, sex, and risk group (random vs. high risk) using generalized estimating equations (GEE)
‡
Variables in model 1 plus additional adjustment for dietary linolenic acid, education, exercise (min/d), smoking (yes/no), alcohol intake (yes/no),
fruit and vegetables, energy intake, and non-chocolate candy (4 groups) consumption.
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Table 3
Prevalence odds ratios (95% confidence intervals) of coronary heart disease according to chocolate
consumption in 4,366 subjects free of diabetes mellitus and subjects who were on weight loss diet*
Frequency of chocolate intake Cases/N Crude Model 1† Model 2‡
0 121/870 1.0 1.0 1.0
1-3 per month 112/1023 0.76 (0.58-1.00) 0.90 (0.65-1.23) 0.98 (0.70-1.36)
1-4 per week 140/17481 0.54 (0.42-0.70) 0.65 (0.49-0.87) 0.68 (0.49-0.94)
5+ per week 32/725 0.29 (0.19-0.43) 0.36 (0.23-0.57) 0.38 (0.23-0.63)
P for linear trend <0.0001 <0.0001 0.0002
*
Coronary heart disease was defined as history of myocardial infarction, PTCA, or CABG.
†
Adjusted for age, sex, and risk group (random vs. high risk) using generalized estimating equations (GEE)
‡
Variables in model 1 plus additional adjustment for dietary linolenic acid, education, exercise (min/d), smoking (yes/no), alcohol intake (yes/no),
fruit and vegetables, energy intake, and non-chocolate candy (4 groups) consumption.
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Table 4
Prevalence odds ratios (95% confidence intervals) of coronary heart disease according to chocolate
consumption and age in 4,970 subjects in the NHLBI Family Heart Study*
Age: ≤ 60 years > 60 years
Frequency of chocolate intake Cases/N OR (95% CI)† Cases/N OR (95% CI)†
0 51/595 1.0 117/498 1.0
1-3 per month 46/763 0.80 (0.49-1.31) 101/404 1.12 (0.78-1.60)
1-4 per week 49/1347 0.48 (0.29-0.79) 133/584 0.90 (0.64-1.27)
5+ per week 13/584 0.36 (0.17-0.75) 30/195 0.48 (0.28-0.83)
P for linear trend 0.0004 0.016
*
Coronary heart disease was defined as history of myocardial infarction, PTCA, or CABG.
†
Adjusted for age, sex, risk group (random vs. high risk), dietary linolenic acid, education, exercise, smoking (yes/no), alcohol intake (yes/no), fruit
and vegetables, energy intake, and non-chocolate candy (4 groups) consumption, using GEE.
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